Are we there yet? Prolonged MAPK inhibition in BRAFV600-mutant melanoma
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference10 articles.
1. The state of melanoma: challenges and opportunities;Merlino;Pigment Cell Melanoma Res,2016
2. Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy;Paraiso;Br J Cancer,2010
3. Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial;Ascierto;Lancet Oncol,2016
4. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma;Larkin;N Engl J Med,2014
5. Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors;Ackerman;Cancer,2014
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced Wild-Type BRAF Melanoma Patients;Journal of Surgical Research;2021-12
2. Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study;BMC Research Notes;2020-03-24
3. Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy;Journal of Translational Medicine;2017-12
4. Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?;International Journal of Molecular Sciences;2017-11-09
5. Melphalan hypoxic perfusion with hemofiltration for melanoma locoregional metastases in the pelvis;Journal of Surgical Research;2017-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3